Release Time:
2026-06-08 15:21

CDH6, also known as **Cadherin-6**, is a calcium-dependent cell adhesion molecule involved in cell-cell interaction, tissue development, and tumor progression. With its elevated expression in several solid tumors and relatively attractive cell-surface localization, CDH6 has become an emerging target in oncology drug development, especially for antibody-based therapies.
CDH6 is highly relevant in ovarian cancer, renal cell carcinoma, endometrial cancer, and other solid tumor research. Its role in tumor invasion, metastasis, and cancer progression makes it a promising membrane protein target for precision oncology strategies.
🧬 CDH6 is highly relevant in:
• Ovarian cancer
• Renal cell carcinoma
• Endometrial cancer
• Cholangiocarcinoma research
• Thyroid cancer research
• Solid tumor drug discovery
🎯 Targeting CDH6 in drug development:
🧪 Antibody-drug conjugates – Deliver cytotoxic payloads to CDH6-expressing tumor cells and support tumor-selective killing.
🧪 Monoclonal antibodies – Explore CDH6 as a surface antigen for antibody-based targeting strategies.
🧪 Patient selection strategies – Use CDH6 expression to identify suitable patient populations for targeted therapy development.
🧪 Combination approaches – Evaluate CDH6-targeted modalities with chemotherapy, immunotherapy, or other oncology treatment backbones.
💥 Challenges include:
• Heterogeneous CDH6 expression
• On-target/off-tumor safety concerns
• Payload and linker optimization for ADCs
• Patient selection and biomarker validation
• Translating early clinical activity into durable benefit
🔬 CDH6 is gaining increasing attention as a promising membrane protein target in solid tumor therapeutics. As CDH6-targeted ADCs and related strategies continue to advance, this target may play an important role in expanding treatment options for ovarian cancer, renal cancer, and other difficult-to-treat solid tumors.
Need CDH6 tools for your research?
Fill out the form below, or visit the link: to browse the complete list of available in-stock products.